Table 1 Patient characteristics

From: Phase II study of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with stage IIIb and IV non-small-cell lung cancer

Characteristics

No of patients

Sex

 

 Male

31

 Female

19

Age (years)

 

 Median

57

 Range

38–71

Performance status (ECOG)

 

 0

7

 1

43

Histology

 

 Adenocarcinoma

40

 Squamous cell carcinoma

8

 Large cell carcinoma

2

Stage

 

 IIIB

16

 IV

34

Site of metastasis

 

 Lung

10

 Brain

14

 Bone

10

 Liver

2

 Adrenal

4

 Abdominal LN

2

Carcinomatous pleurisy

17

Back to article page